Pharma Times

NOVEMBER 27, 2020

It is hoped that the test will help detect cancer at a much earlier stage

159

159

NY Times

NOVEMBER 27, 2020

Court filings reveal consultants’ talk of a records purge during the opioid crisis, and shed new light on sales advice given to the billionaire Sackler family and their drug company, Purdue Pharma.

145

145

pharmaphorum

NOVEMBER 24, 2020

A merger involving two US digital health specialists and a blank cheque company has created a telemedicine player, called UpHealth, that is valued at more than $1.3 billion. The three-way deal combines UpHealth – which provides patient care management, telemedicine and digital pharmacy services and gives its name to the new group – with CloudBreak, which provides a video consultation platform for doctors and patients.

Packaging 138

Packaging Compounding 138

Drug Patent Watch

NOVEMBER 27, 2020

Annual Drug Patent Expirations for KORLYM Korlym is a drug marketed by Corcept Therap and is included in one NDA. There are fourteen patents protecting this drug and one Paragraph…. The post New patent for Corcept Therap drug KORLYM appeared first on DrugPatentWatch - Make Better Decisions.

98

98

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

Pharma Times

NOVEMBER 27, 2020

The combination is the first available to treat the underlying cause of CF in this patient group.

146

146

pharmaphorum

NOVEMBER 27, 2020

Amanda Barrell explores how a perfect storm of changing economics, advances in technology, and the increasing volume of the patient voice is stoking change in the rare disease space. New models of drug development are fuelling life-changing advantages in the rare disease space, previously an economic no-go area for pharma and biotech companies. That was among the discussion points during Fighting Rare Diseases – The Science, Economics and the Patients , a webinar hosted by o2h Group.

Drug Development 132

Drug Development 132

Drug Patent Watch

NOVEMBER 25, 2020

Annual Drug Patent Expirations for XYOSTED+%28AUTOINJECTOR%29 Xyosted (autoinjector) is a drug marketed by Antares Pharma Inc and is included in one NDA. It is available from one supplier. There are…. The post New patent for Antares Pharma drug XYOSTED (AUTOINJECTOR) appeared first on DrugPatentWatch - Make Better Decisions.

98

98

Pharma Times

NOVEMBER 25, 2020

Shot will be evaluated in pregnant mothers and their newborn infants

Vaccines 137

Vaccines 137

NY Times

NOVEMBER 23, 2020

The billionaire is working with the W.H.O., drugmakers and nonprofits to defeat the coronavirus everywhere, including in the world’s poorest nations. Can they do it?

Vaccines 143

Vaccines 143

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

pharmaphorum

NOVEMBER 23, 2020

Janssen’s Daniel de Schryver tells us why it’s time to give patients a permanent seat at the table and improve health outcomes through patient-pharma dialogue. I’m struck by just how much we thrive when we share a common purpose; when – as a society, a group or a family unit – we work together to achieve the same goal. It’s no different in healthcare.

Communication 128

Communication Documentation Vaccines 128

Outsourcing Pharma

NOVEMBER 23, 2020

The pharma giant and the clinical-stage drug developer will join on a pilot study investigating a candidateâs potential in overcoming resistance of a cancer drug.

Drug Development 97

Drug Development 97

Pharma Times

NOVEMBER 25, 2020

New report conducted by Imperial College London researchers and Philips UK highlights issues within the NHS

135

135

NY Times

NOVEMBER 23, 2020

The drug maker said its vaccine candidate was 70 percent effective on average, and potentially up to 90 percent effective, at preventing Covid-19 in an early analysis.

Vaccines 105

Vaccines 105

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

pharmaphorum

NOVEMBER 25, 2020

An artificial intelligence tool developed by GE Healthcare twinned with a mobile X-ray device can help the placement of endotracheal tubes (ETTs), a necessary step for COVID-19 patients who require ventilation. The new tool – part of GE’s Critical Care Suite 2.0 – helps bedside staff and radiologists assess patients before intubation and make sure ETTs are positioned correctly which should reduce complications.

Hospitals 122

Hospitals 122

Drug Patent Watch

NOVEMBER 24, 2020

Annual Drug Patent Expirations for RISPERDAL+CONSTA Risperdal Consta is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There is one…. The post New patent expiration for Janssen Pharms drug RISPERDAL CONSTA appeared first on DrugPatentWatch - Make Better Decisions.

96

96

Pharma Times

NOVEMBER 26, 2020

Sanofi's Sarclisa gets the final green light for use by the NHS with funding from the CDF

132

132

Outsourcing Pharma

NOVEMBER 24, 2020

The two companies will collaborate on a Phase III clinical trial investigating a potential treatment for patients hospitalized with COVID-19.

Hospitals 96

Hospitals 96

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

NOVEMBER 25, 2020

AstraZeneca’s research chief has said that the more effective dosing regimen of its coronavirus vaccine was discovered by accident. According to Reuters , the AstraZeneca development team made a minor mistake that made them realise they could significantly boost the success rate of the vaccine, codenamed AZD1222. Results announced earlier this week showed that by giving a half dose, followed by a full dose a month later, the vaccine’s efficacy could be boosted from 62% to around 90%.

Vaccines 119

Vaccines Compounding 119

Drug Patent Watch

NOVEMBER 26, 2020

Annual Drug Patent Expirations for NEUPRO Neupro is a drug marketed by Ucb Inc and is included in one NDA. It is available from one supplier. There are eight patents…. The post New patent expiration for Ucb Inc drug NEUPRO appeared first on DrugPatentWatch - Make Better Decisions.

88

88

Pharma Times

NOVEMBER 27, 2020

Trial results and cost-effectiveness are too uncertain for NHS use, the Institute said

131

131

NY Times

NOVEMBER 22, 2020

The nonprofit marketing group led a polio vaccine campaign in the 1950s. Now it is working on a $50 million ad blitz to counter concerns about coming treatments.

Vaccines 73

Vaccines 73

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

pharmaphorum

NOVEMBER 25, 2020

Novartis’ pipeline is strong enough to overcome a $14 billion patent cliff as blockbuster drugs face generic competition in the coming years, analysts have said. Following a briefing with management, a team of analysts led by Peter Welford said that the big Swiss pharma will be propped up by its psoriasis and infectious diseases blockbuster Cosentyx for some time.

Biosimilars 119

Biosimilars Hospitals 119

Outsourcing Pharma

NOVEMBER 23, 2020

The agency has given the go-ahead for use of baricitinib in conjunction with remdesivir for treating patients hospitalized with severe cases of the virus.

Hospitals 63

Hospitals 63

Pharma Times

NOVEMBER 25, 2020

Deal will focus on developing small molecules against a number of diseases

130

130

NY Times

NOVEMBER 22, 2020

The nonprofit marketing group led a polio vaccine campaign in the 1950s. Now it is working on a $50 million ad blitz to counter concerns about coming treatments.

Vaccines 63

Vaccines 63

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.